Aadi Bioscience
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aadi Bioscience generated cash of -$59,663,000, which is less than the previous year. Cash used in financing activities reached the amount of $326,000 last year. Net change in cash is therefore $23,869,000.
Cash Flow
| 2014 | -23.32K | 0 | 25K |
|---|---|---|---|
| 2015 | -17.88M | -41.03K | 3K |
| 2016 | -15.71M | -113.29K | 12.29M |
| 2017 | -18.88M | 41.10K | 37.49M |
| 2018 | -5.80M | -37.91K | 48.19M |
| 2019 | -23.85M | -236.95K | 8.07M |
| 2020 | -12.70M | -19.02K | 1.19M |
| 2021 | -22.42M | 25.15M | 141.80M |
| 2022 | -49.64M | -132.88M | 72.62M |
| 2023 | -59.66M | 83.20M | 326K |
AADI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 39.08M | 148.98M | 4.45M | 15.96M | 62.61M | 20.26M | 1.60M | 18.52K | 5.26K | 3.58K |
Operating activities | ||||||||||
Net income | -65.76M | -60.51M | -110.09M | -3.47M | -23.27M | -10.39M | -21.40M | -16.98M | -17.07M | -28.70K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 169K | 159K | 105K | 9K | 76.50K | 46.68K | 51.26K | 69.67K | 57.97K | 0 |
Stock-based compensation expense | 11.95M | 9.64M | 2.10M | 139K | 106.14K | 0 | 649.40K | 0 | 0 | 0 |
| Deferred income tax benefit | 11.95M | 9.64M | 2.10M | 139K | 106.14K | 0 | 649.40K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3.62M | -1.86M | 14.14M | -13.86M | -39.70K | 0 | 1.60M | 0 | 0 | 0 |
Inventories | -3.26M | -1.86M | 0 | 0 | 39.70K | 0 | -1.38M | 0 | 0 | 0 |
Accounts payable | -132K | 3.22M | 8.29M | 1.07M | -2.21M | 1.86M | 1.60M | 600 | 1.27K | -1.5K |
Cash generated by operating activities | -59.66M | -49.64M | -22.42M | -12.70M | -23.85M | -5.80M | -18.88M | -15.71M | -17.88M | -23.32K |
Investing activities | ||||||||||
Purchases Of Investments | -64.43M | -145.19M | 0 | 0 | 0 | 0 | -41.10K | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3.97M | -444K | -46K | 0 | -236.95K | -37.91K | -8.89K | -113.29K | -41.03K | 0 |
Acquisitions Net | 0 | 132.44M | 25.19M | 0 | 0 | 0 | 50K | 0 | 0 | 0 |
Cash generated by investing activities | 83.20M | -132.88M | 25.15M | -19.02K | -236.95K | -37.91K | 41.10K | -113.29K | -41.03K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 326K | 72.5M | 155M | 9.74M | 0 | 51.69M | 40.28M | 18.96K | 3K | 0 |
Payments for dividends | 0 | 0 | -4.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.26K |
Repayments of term debt | 0 | 0 | 0 | -997K | 8.07M | 0 | 297.35K | -12.54M | 0 | 0 |
Cash used in financing activities | 326K | 72.62M | 141.80M | 1.19M | 8.07M | 48.19M | 37.49M | 12.29M | 3K | 25K |
Net Change In Cash | 23.86M | -109.90M | 144.53M | -11.50M | -24.08M | 42.34M | 18.65M | 1.59M | 5.13M | 1.67K |
Cash at end of period | 62.95M | 39.08M | 148.98M | 4.45M | 38.52M | 62.61M | 20.26M | 1.60M | 5.14M | 5.26K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |